This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

PhotoMedex Reports Third Quarter 2012 Financial Results

PhotoMedex, Inc. (NASDAQ and TASE: PHMD) today reported financial results for the three and nine months ended September 30, 2012. Financial highlights of the 2012 third quarter include:

  • Revenues of $56.7 million, an increase of 63% compared with the prior-year third quarter and a decrease of 4% sequentially
  • Net income of $7.5 million, an increase of 77% compared with the prior-year third quarter and an increase of 79% sequentially
  • Consumer revenues of $49.6 million, an increase of 48% compared with the prior-year third quarter and a decrease of 2% sequentially
  • Direct-to-consumer channel revenues of $30.0 million, an increase of 61% compared with the prior-year third quarter and a decrease of 11% sequentially
  • Distributor consumer channel revenues of $9.4 million, an increase of 11% compared with the prior-year third quarter and an increase of 34% sequentially
  • Global retail and home shopping channel revenues of $10.2 million, an increase of 57% compared with the prior-year third quarter and an increase of 5% sequentially
  • Gross profit of $45.4 million, an increase of 71% compared with the prior-year third quarter and a decrease of 3% sequentially
  • Gross margin of 80.1% compared with gross margin of 76.6% in the prior-year third quarter and 79.0% in the 2012 second quarter; prior-year third quarter gross margin does not include revenues from the pre-merged PhotoMedex
  • Cash generated from operations was $8.7 million in the 2012 third quarter; during the quarter the company repurchased $5.3 million or 424,244 shares of its common stock at an average price of $12.59 per share for a total of $5.3 million

On December 13, 2011 Radiancy, Inc. became a majority owned subsidiary of PhotoMedex in a reverse merger. In accordance with generally accepted accounting principles (GAAP), Radiancy is deemed to be the financial acquirer for financial statement purposes and therefore the related consolidated statements of operations for the periods prior to the merger date do not include activity from the pre-merged PhotoMedex.

1 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs